Genetic test reporting of CDKN2A provides informational and motivational benefits for managing melanoma risk

A CDKN2A/p16 mutation confers 28%–67% lifetime melanoma risk, a risk that may be moderated by ultraviolet radiation exposure. The aim of this study was to test whether melanoma genetic counseling and test disclosure conferred unique informational, motivational, or emotional benefits compared to fami...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Transl Behav Med
Hlavní autoři: Aspinwall, Lisa G, Stump, Tammy K, Taber, Jennifer M, Drummond, Danielle M, Kohlmann, Wendy, Champine, Marjan, Leachman, Sancy A
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6065541/
https://ncbi.nlm.nih.gov/pubmed/29385581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/tbm/ibx011
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky